iGreenSwiss

iGreenSwiss PIONEERS IN SWISS MEDICAL CANNABIS iGreen Swiss is a substainable and responsible pharmaceutical company.

We are committed to a biologically and environmentally sustainable production. We are specialized in the production, research and development of medicinal plants, and in particular in medical cannabis. We are a vertically integrated company that encompasses all phases of our activities under one roof. Our team of experts is dedicated to the manufacture of Tetrahydrocannabinol (THC), Cannabidiol (CBD) and other cannabinoids used to prepare finished and semi-finished products for therapeutic use. Our product range extends from processed raw material (dried trimmed flowers) to refined extracts and concentrates (oils). All our products are made in Switzerland in accordance with Swiss ‘bio-cultivation’ norms and inspired by nature and ecology. Since 2018, our company has been preparing its application to the FOPH (OFSP/BAG) for an exceptional license to cultivate and process medical cannabis with a high level of Tetrahydrocannabinol (THC > 1%). The FOPH has been monitoring our company and we are updating them with our progress. We expect to be able to provide Swiss pharmacies with our products at the end of 2022, after receiving all authorisations and licenses from FOPH and Swissmedic (exceptional licenses & GMP for medicinal products).

Une femme s’auto-traitant uniquement avec du CBD voit la taille de sa tumeur régresser de 76%https://trustmyscience.com/...
20/10/2021

Une femme s’auto-traitant uniquement avec du CBD voit la taille de sa tumeur régresser de 76%

https://trustmyscience.com/femme-taille-tumeur-regresse-avec-consommation-cbd/

Des médecins rapportent qu'une octogénaire atteinte d'un cancer du poumon et ayant refusé le traitement standard a vu la taille de sa tumeur diminuer de 76% en trois ans, après avoir commencé son traitement à base d'huile de CBD.

New survey involving fibromyalgia patients. “Cannabis should be seriously considered in every ‘chronic pain condition’ w...
13/10/2021

New survey involving fibromyalgia patients. “Cannabis should be seriously considered in every ‘chronic pain condition’ whenever the accepted modalities of treatment are insufficient for alleviating patient’s pain and sleep problems.” the researchers concluded.
https://cannatechtoday.com/fibromyalgia-patients-report-less-pain-improved-sleep-after-cannabis/

Researchers conducted a survey to determine if medical cannabis was an effective treatment for fibromyalgia patients.

Cannabis thérapeutique : «ses propriétés anticancéreuses ont été clairement démontrées chez l'homme»https://www.pourquoi...
27/07/2021

Cannabis thérapeutique : «ses propriétés anticancéreuses ont été clairement démontrées chez l'homme»
https://www.pourquoidocteur.fr/Articles/Question-d-actu/36898-Cannabis-therapeutique-ses-proprietes-anticancereuses-clairement-demontrees-l-homme

Alors que 78% des Français sont en faveur de la légalisation du cannabis médical et que l'ANSM a lancé une grande étude sur la question, le Dr Franjo Grotenhermen, directeur exécutif de l’IACM (International association for cannabinoïd medicines), fait le point sur ce dossier. .

Europe’s H**p Farmers Struggling to Keep-Up With Soaring Demand, Finds New Report.https://businesscann.com/europes-h**p-...
27/07/2021

Europe’s H**p Farmers Struggling to Keep-Up With Soaring Demand, Finds New Report.
https://businesscann.com/europes-h**p-farmers-struggling-to-keep-up-with-soaring-demand-finds-new-report/

THE soaring global demand for h**p is demonstrated in the latest CanXChange Benchmark Report which shows that 60% of this year’s European crop has been pre-sold – with orders already placed for 2022. CanXchange, which went live in February 2020, is a physical commodity exchange and wholesale dat...

Majority of Swiss support the legalisation of cannabis.https://www.swissinfo.ch/eng/majority-of-swiss-support-the-legali...
08/07/2021

Majority of Swiss support the legalisation of cannabis.
https://www.swissinfo.ch/eng/majority-of-swiss-support-the-legalisation-of-cannabis/46751234

Most Swiss accept the idea of legalising cannabis for recreational purposes provided there are rules to protect minors, according to a survey published on Thursday. Nearly two-thirds of people surveyed want the minimum age of consumption to be set at 18, the Federal Office of Public Health (FOPH) sa...

Address


1525

Opening Hours

Monday 08:00 - 17:00
Tuesday 08:00 - 17:00
Wednesday 08:00 - 17:00
Thursday 08:00 - 17:00
Friday 08:00 - 17:00

Alerts

Be the first to know and let us send you an email when iGreenSwiss posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to iGreenSwiss:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram